Technical Analysis for BSGM - BioSig Technologies, Inc.

Grade Last Price % Change Price Change
grade B 6.1 2.69% 0.16
BSGM closed down 3.26 percent on Monday, March 25, 2019, on 50 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical BSGM trend table...

Date Alert Name Type % Chg
Mar 25 Fell Below 20 DMA Bearish 2.69%
Mar 25 1,2,3 Pullback Bullish Bullish Swing Setup 2.69%
Mar 25 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.69%
Mar 25 Calm After Storm Range Contraction 2.69%
Mar 25 NR7 Range Contraction 2.69%
Mar 25 Inside Day Range Contraction 2.69%
Mar 25 Wide Bands Range Expansion 2.69%
Mar 22 MACD Bearish Signal Line Cross Bearish -0.65%
Mar 22 20 DMA Support Bullish -0.65%
Mar 22 Golden Cross Bullish -0.65%

Older signals for BSGM ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
BioSig Technologies is a medical device company developing a proprietary biomedical signal processing technology designed to improve the $4.6 billion electrophysiology (EP) marketplace (www.biosigtech.com). Led by a proven management team and a veteran, independent Board of Directors, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP(TM) System. The technology has been developed to address an unmet need in a large and growing market. The Company’s first product, PURE EP(TM) System, is a novel cardiac signal acquisition and display system which is engineered to assist electrophysiologists in clinical decision making during procedures to diagnose and treat patients with abnormal heart rates and rhythms. BioSig’s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias: Atrial Fibrillation and Ventricular Tachycardia. BioSig has partnered with Minnetronix on technology development and received FDA 510(k) clearance for the PURE EP(TM) System in August 2018.
FDA Circulatory System Cardiac Electrophysiology Cardiovascular System Atrial Fibrillation Technology Development Cardiac Arrhythmia Catheter Ablation Heart Arrhythmia
Is BSGM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.875
52 Week Low 3.5
Average Volume 77,953
200-Day Moving Average 5.0568
50-Day Moving Average 5.0886
20-Day Moving Average 5.978
10-Day Moving Average 6.449
Average True Range 0.4016
ADX 49.75
+DI 26.2743
-DI 17.9604
Chandelier Exit (Long, 3 ATRs ) 6.1102
Chandelier Exit (Short, 3 ATRs ) 6.2948
Upper Bollinger Band 7.1617
Lower Bollinger Band 4.7943
Percent B (%b) 0.48
BandWidth 39.601874
MACD Line 0.3841
MACD Signal Line 0.4364
MACD Histogram -0.0523
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.30
Resistance 3 (R3) 6.33 6.24 6.24
Resistance 2 (R2) 6.24 6.15 6.23 6.22
Resistance 1 (R1) 6.09 6.09 6.05 6.06 6.20
Pivot Point 6.00 6.00 5.98 5.99 6.00
Support 1 (S1) 5.85 5.91 5.81 5.82 5.68
Support 2 (S2) 5.76 5.85 5.75 5.66
Support 3 (S3) 5.61 5.76 5.64
Support 4 (S4) 5.58